FATE THERAPEUTICS INC (FATE) Operating income 2016–2025
FATE THERAPEUTICS INC (FATE) annual operating income history from SEC filings — each fiscal year as reported.
-$147.7MFY2025 · since FY2016: -$32.0M → -$147.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$147.7M | +29.8% |
| FY2024 | -$210.3M | -10.4% |
| FY2023 | -$190.5M | +38.2% |
| FY2022 | -$308.4M | -42.1% |
| FY2021 | -$217.0M | -69.4% |
| FY2020 | -$128.1M | -27.2% |
| FY2019 | -$100.7M | -50.1% |
| FY2018 | -$67.1M | -59.3% |
| FY2017 | -$42.1M | -31.8% |
| FY2016 | -$32.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More FATE financial trends
FATE RevenueFATE Net incomeFATE Net marginFATE Gross profitFATE Gross marginFATE Operating marginFATE Operating cash flowFATE Free cash flowFATE Capital expendituresFATE Return on equityFATE Stock buybacksFATE Dividends paidFATE Total assetsFATE Total liabilitiesFATE Shareholders’ equityFATE overview →